|
F6T
|
Fate Therapeutics Inc
|
DE
|
F
|
|
G1G
|
Zelira Therapeutics Limited
|
DE
|
F
|
|
G51
|
Genscript Biotech Corporation
|
DE
|
F
|
|
GPH
|
Galmed Pharmaceuticals Ltd
|
DE
|
F
|
|
H2K2
|
XTL Biopharmaceuticals Ltd
|
DE
|
F
|
|
HPHA
|
Heidelberg Pharma AG
|
DE
|
F
|
|
HYVN
|
Haynes International Inc
|
DE
|
F
|
|
I7G
|
Ipsen S.A
|
DE
|
F
|
|
I7G0
|
IPSEN SA SP.ADR 1/4/ EO 1
|
DE
|
F
|
|
ICY
|
Incyte Corporation
|
DE
|
F
|
|
IF0
|
InflaRx N.V
|
DE
|
F
|
|
IKAP
|
Aurinia Pharmaceuticals Inc
|
DE
|
F
|
|
IM8N
|
Insmed Incorporated
|
DE
|
F
|
|
ITH
|
Nektar Therapeutics
|
DE
|
F
|
|
KUR
|
Kura Oncology Inc
|
DE
|
F
|
|
LDBA
|
H. LUNDBECK A/S SER.B DK1
|
DE
|
F
|
|
LDBB
|
H. LUNDBECK A/S SER.A DK1
|
DE
|
F
|
|
LGDN
|
Ligand Pharmaceuticals Incorporated
|
DE
|
F
|
|
LO3A
|
LONZA GROUP UNSP.ADR 1/10
|
DE
|
F
|
|
LT4
|
LIQUIDIA CORP. DL-001
|
DE
|
F
|